|
Government funding for synthetic biology is on the rise, but the way in which society responds to new technologies is an important factor in their success or failure. With synthetic biology, so far, civil society organizations (CSOs) seem to build on their 1980’s genetic engineering strategy: they focus on the risks of synthetic biology, and call for a moratorium and stricter regulation. Scientists and public policy authorities seem to have learned their GMO lessons. There is an increased awareness of the importance of public engagement in potentially controversial technological developments.
A new and first-of-its-kind analysis by the US Woodrow Wilson Center found that the U.S. government has spent around $430 million on research related to synthetic biology since 2005, with the Department of Energy funding a majority of the research. By comparison, the analysis indicated that the European Union and three individual European countries – the Netherlands, United Kingdom, and Germany – had spent approximately $160 million during that same period. Estimates have placed the current annual synthetic biology research market at $600 million, a sum that has the potential to exceed $3.5 billion over the next decade. The list of potential applications in energy, environment, health and other areas is long and growing. Along with its potential benefits, there are also concerns about the ethical, legal and social implications of synthetic biology. In response to these concerns, approximately 4 percent of the U.S. funding and 2 percent of the European funding is being spent for so-called ELSI research.
CSO testimony
Synthetic biology is also increasingly grasping attention from CSOs. In a hearing by the U.S. House of Representatives Energy and Commerce Committee, Friends of the Earth, the ETC Group and the International Center for Technology Assessment sent a testimony to the committee’s chairman, calling on the Congress to implement a moratorium on the release of synthetic organisms into the environment and also their use in commercial settings. This moratorium should remain in place until there is an adequate scientific basis on which to justify such activities, and until due consideration of the associated risks for the environment, biodiversity, and human health, and all associated socio-economic repercussions, are fully and transparently considered. Testbiotech, a German CSO concerned with the ecological, social and ethical aspects of biotechnology, has launched an initiative with more or less the same demands.
Public dialogue
Besides CSO’s responses and activities, there are strong calls for more effective public engagement, without which “there will be no synthetic biology in Europe” according to Colin Macilwain in a column in Nature of June 16th, 2010. This lesson, learnt from the European debate on genetically modified crops, is at the heart of Academies of Science, Research Councils and Technology Assessment institutes in several European countries. Recently, a public panel debate in Berlin, hosted by the German Ethics Council, attracted several hundreds of people. The most extensive public involvement activity to date, is the British Synthetic Biology Dialogue, which engaged both stakeholders and citizens all over the country in a debate on synthetic biology. It resulted in a broad spectrum of conclusions. Strikingly, apart from the issues of newness and risks, most conclusions are related to the governance of science and technology in a more general sense.
More about funding
Pauwels, Eleonore. Review of quantitative and qualitative studies on U.S. public perceptions of synthetic biology. SystSynth Biol (2009) 3:37–46 DOI 10.1007/s11693-009-9035-6
More about CSO’s responses
Friends of the Earth, International Center for Technology Assessment, ETC group, Offering Testimony from Civil Society on the Environmental and Societal Implications of Synthetic Biology, May 26, 2010
Christoph Then, Sylvia Hamberger, Synthetische Biologie Teil 1: Synthetische Biologie und künstliches Leben – Eine kritsiche Analyse, München, Juni 2010
More about public dialogue
Colin Macilwain, World view: Talking the talk, Nature 465, 867 (2010) | doi:10.1038/465867a
BBRSC Synthetic Biology Dialogue
Nicole Kronberger et.al.. Communicating Synthetic Biology: from the lab via the media to the broader public, Syst Synth Biol (2009) 3:19–26 DOI 10.1007/s11693-009-9031-x
|